MEAGAN TATE: Open Payments
NPI 1235670753 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,302 in 71 payments from 19 companies in 2025. Trend: 2023 $750 · 2024 $1,358 · 2025 $1,302
Food & beverage: $1,302
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 18 | $255 |
| Novo Nordisk Inc | 12 | $206 |
| PFIZER INC. | 10 | $194 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $171 |
| Exact Sciences Corporation | 4 | $68 |
| Biogen, Inc. | 1 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $55 |
| Actelion Pharmaceuticals US, Inc. | 1 | $40 |
| Astellas Pharma US Inc | 2 | $39 |
| ABBVIE INC. | 2 | $38 |
Products named: XIFAXAN, Wegovy, PREVNAR 20, MOUNJARO, JARDIANCE, Cologuard Collection Kit, ZURZUVAE, REXULTI.
Industry payments across TN — which companies pay providers there.
